173 related articles for article (PubMed ID: 17725851)
1. Effects of low oxygen levels on the expression and function of transporter OCTN2 in BeWo cells.
Rytting E; Audus KL
J Pharm Pharmacol; 2007 Aug; 59(8):1095-102. PubMed ID: 17725851
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-mediated down-regulation of OCTN2 and PPARα expression in human placentas and in BeWo cells.
Chang TT; Shyu MK; Huang MC; Hsu CC; Yeh SY; Chen MR; Lin CJ
Mol Pharm; 2011 Feb; 8(1):117-25. PubMed ID: 21125992
[TBL] [Abstract][Full Text] [Related]
3. Regulation of protein expression and function of octn2 in forskolin-induced syncytialization in BeWo Cells.
Huang FD; Kung FL; Tseng YC; Chen MR; Chan HS; Lin CJ
Placenta; 2009 Feb; 30(2):187-94. PubMed ID: 19091402
[TBL] [Abstract][Full Text] [Related]
4. Novel organic cation transporter 2-mediated carnitine uptake in placental choriocarcinoma (BeWo) cells.
Rytting E; Audus KL
J Pharmacol Exp Ther; 2005 Jan; 312(1):192-8. PubMed ID: 15316089
[TBL] [Abstract][Full Text] [Related]
5. Expression and localization of carnitine/organic cation transporter OCTN1 and OCTN2 in ocular epithelium.
Garrett Q; Xu S; Simmons PA; Vehige J; Flanagan JL; Willcox MD
Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4844-9. PubMed ID: 18641280
[TBL] [Abstract][Full Text] [Related]
6. Oxaliplatin transport mediated by organic cation/carnitine transporters OCTN1 and OCTN2 in overexpressing human embryonic kidney 293 cells and rat dorsal root ganglion neurons.
Jong NN; Nakanishi T; Liu JJ; Tamai I; McKeage MJ
J Pharmacol Exp Ther; 2011 Aug; 338(2):537-47. PubMed ID: 21606177
[TBL] [Abstract][Full Text] [Related]
7. Functional expression of the organic cation/carnitine transporter 2 in rat astrocytes.
Inazu M; Takeda H; Maehara K; Miyashita K; Tomoda A; Matsumiya T
J Neurochem; 2006 Apr; 97(2):424-34. PubMed ID: 16539668
[TBL] [Abstract][Full Text] [Related]
8. Carnitine/organic cation transporter OCTN2-mediated transport of carnitine in primary-cultured epididymal epithelial cells.
Kobayashi D; Irokawa M; Maeda T; Tsuji A; Tamai I
Reproduction; 2005 Dec; 130(6):931-7. PubMed ID: 16322553
[TBL] [Abstract][Full Text] [Related]
9. OCTN2-mediated transport of carnitine in isolated Sertoli cells.
Kobayashi D; Goto A; Maeda T; Nezu J; Tsuji A; Tamai I
Reproduction; 2005 Jun; 129(6):729-36. PubMed ID: 15923388
[TBL] [Abstract][Full Text] [Related]
10. Localization of organic cation/carnitine transporter (OCTN2) in cells forming the blood-brain barrier.
Miecz D; Januszewicz E; Czeredys M; Hinton BT; Berezowski V; Cecchelli R; Nałecz KA
J Neurochem; 2008 Jan; 104(1):113-23. PubMed ID: 17995936
[TBL] [Abstract][Full Text] [Related]
11. Transport of ipratropium, an anti-chronic obstructive pulmonary disease drug, is mediated by organic cation/carnitine transporters in human bronchial epithelial cells: implications for carrier-mediated pulmonary absorption.
Nakamura T; Nakanishi T; Haruta T; Shirasaka Y; Keogh JP; Tamai I
Mol Pharm; 2010 Feb; 7(1):187-95. PubMed ID: 20020740
[TBL] [Abstract][Full Text] [Related]
12. PDZ adaptor protein PDZK2 stimulates transport activity of organic cation/carnitine transporter OCTN2 by modulating cell surface expression.
Watanabe C; Kato Y; Sugiura T; Kubo Y; Wakayama T; Iseki S; Tsuji A
Drug Metab Dispos; 2006 Nov; 34(11):1927-34. PubMed ID: 16896066
[TBL] [Abstract][Full Text] [Related]
13. Regulation of testis-specific carnitine transporter (octn3) gene by proximal cis-acting elements Sp1 in mice.
Maeda T; Hirayama M; Kobayashi D; Tamai I
Biochem Pharmacol; 2005 Sep; 70(6):858-68. PubMed ID: 16051193
[TBL] [Abstract][Full Text] [Related]
14. Fasting and caloric restriction increases mRNA concentrations of novel organic cation transporter-2 and carnitine concentrations in rat tissues.
Luci S; Hirche F; Eder K
Ann Nutr Metab; 2008; 52(1):58-67. PubMed ID: 18309235
[TBL] [Abstract][Full Text] [Related]
15. Expression of novel organic cation/carnitine transporter (OCTN2) in the mouse pancreas.
Kai S; Yakushiji K; Yamauchi M; Ito C; Kuwajima M; Osada Y; Toshimori K
Tissue Cell; 2005 Aug; 37(4):309-15. PubMed ID: 15896819
[TBL] [Abstract][Full Text] [Related]
16. The inhibitory effects of fluoroquinolones on L-carnitine transport in placental cell line BeWo.
Hirano T; Yasuda S; Osaka Y; Asari M; Kobayashi M; Itagaki S; Iseki K
Int J Pharm; 2008 Mar; 351(1-2):113-8. PubMed ID: 17977676
[TBL] [Abstract][Full Text] [Related]
17. Involvement of OCTN2 and B0,+ in the transport of carnitine through an in vitro model of the blood-brain barrier.
Berezowski V; Miecz D; Marszałek M; Bröer A; Bröer S; Cecchelli R; Nałecz KA
J Neurochem; 2004 Nov; 91(4):860-72. PubMed ID: 15525340
[TBL] [Abstract][Full Text] [Related]
18. A missense mutation in the OCTN2 gene associated with residual carnitine transport activity.
Wang Y; Kelly MA; Cowan TM; Longo N
Hum Mutat; 2000; 15(3):238-45. PubMed ID: 10679939
[TBL] [Abstract][Full Text] [Related]
19. Organic cation/carnitine transporter OCTN2 (Slc22a5) is responsible for carnitine transport across apical membranes of small intestinal epithelial cells in mouse.
Kato Y; Sugiura M; Sugiura T; Wakayama T; Kubo Y; Kobayashi D; Sai Y; Tamai I; Iseki S; Tsuji A
Mol Pharmacol; 2006 Sep; 70(3):829-37. PubMed ID: 16754783
[TBL] [Abstract][Full Text] [Related]
20. Studies on functional sites of organic cation/carnitine transporter OCTN2 (SLC22A5) using a Ser467Cys mutant protein.
Ohashi R; Tamai I; Inano A; Katsura M; Sai Y; Nezu J; Tsuji A
J Pharmacol Exp Ther; 2002 Sep; 302(3):1286-94. PubMed ID: 12183691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
